Drugs - Real World Outcomes View Homepage


Ontology type: schema:Periodical      Open Access: True


Journal Info

START YEAR

2014

PUBLISHER

Springer International Publishing

LANGUAGE

en

HOMEPAGE

http://link.springer.com/journal/40801

Recent publications latest 20 shown

  • 2019-03-27 Adverse Events Associated with Risperidone Use in Pediatric Patients: A Retrospective Biobank Study
  • 2019-03 Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
  • 2019-03 Epidemiological Profile of Drug Overdose Reported in South-East Morocco from 2004 to 2016
  • 2019-03 Tolerability of Isoniazid Preventive Therapy in an HIV-Infected Cohort of Paediatric and Adolescent Patients on Antiretroviral Therapy from a Resource-Limited Setting: A Retrospective Cohort Study
  • 2019-03 Characterization of Patients with Ankylosing Spondylitis Receiving Secukinumab and Reasons for Initiating Treatment: A US Physician Survey and Retrospective Medical Chart Review
  • 2019-03 Effects of Intravenous Landiolol on Heart Rate and Outcomes in Patients with Atrial Tachyarrhythmias and Acute Decompensated Heart Failure: A Single-Center Experience
  • 2018-12 Acknowledgement to Referees
  • 2018-12 Inappropriate Prescribing in Elderly Inpatients at a University Hospital in Saudi Arabia
  • 2018-12 Impact of Definitive Drug–Drug Interaction Testing on Medication Management and Patient Care
  • 2018-12 Impact of Age, Comorbidity, and FIGO Stage on Treatment Choice and Mortality in Older Danish Patients with Gynecological Cancer: A Retrospective Register-Based Cohort Study
  • 2018-09 Patient Understanding of the Neuropsychiatric Risks Associated with Branded Bupropion Hydrochloride Products Used for Smoking Cessation
  • 2018-09 Real-World Adverse Effects of Capecitabine Toxicity in an Elderly Population
  • 2018-09 Recent Trends in the Practice of Procedural Sedation Under Local Anesthesia for Catheter Ablation, Gastrointestinal Endoscopy, and Endoscopic Surgery in Japan: A Retrospective Database Study in Clinical Practice from 2012 to 2015
  • 2018-09 Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs
  • 2018-09 Clinical Outcomes with First-Line Chemotherapy in a Large Retrospective Study of Patients with Metastatic Pancreatic Cancer Treated in a US Community Oncology Setting
  • 2018-09 Safety Profile of Drug Use During Pregnancy at Peripheral Health Centres in Burkina Faso: A Prospective Observational Cohort Study
  • 2018-06 Compliance with Pregnancy Prevention Recommendations for Isotretinoin in Estonia in 2012–2016
  • 2018-06 Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
  • 2018-06 Use of Topical Tacrolimus and Topical Pimecrolimus in Four European Countries: A Multicentre Database Cohort Study
  • 2018-06 An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H69000", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Pharmacotherapy", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/B21007", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Pharmacology/Toxicology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://scigraph.springernature.com/ontologies/product-market-codes/H33002", 
            "inDefinedTermSet": "http://scigraph.springernature.com/ontologies/product-market-codes/", 
            "name": "Internal Medicine", 
            "type": "DefinedTerm"
          }
        ], 
        "description": "

    Drugs - Real World Outcomes targets research involving the use of real-world data to evaluate health outcomes and inform healthcare decision-making, with a particular focus on healthcare-related 'big data'. Drugs - Real World Outcomes has a broad scope, encompassing studies investigating drug utilisation, patterns of prescribing, pharmacovigilance, treatment guideline adherence, benefit-risk assessments, comparative effectiveness and economic analyses.

    Drugs - Real World Outcomes offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal\u2019s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager\u00ae, supported by a database of international experts. This database is shared with other Adis journals.

    Upon acceptance for publication, manuscripts submitted to the journal will be subject to an article processing charge (APC) of US$2,200. Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of the APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) License, which does not permit commercial re-use ofthe article.

    ", "editor": [ { "familyName": "Peters", "givenName": "Dene", "type": "Person" } ], "id": "sg:journal.1051855", "inLanguage": [ "en" ], "isAccessibleForFree": true, "issn": [ "2199-1154", "2198-9788" ], "license": "Fully Open Access", "name": "Drugs - Real World Outcomes", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "51855" ] }, { "name": "springer_id", "type": "PropertyValue", "value": [ "40801" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "2015243440" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "101658456" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "489866" ] } ], "publisher": { "name": "Springer International Publishing", "type": "Organization" }, "publisherImprint": "Adis", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1051855" ], "sdDataset": "journals", "sdDatePublished": "2021-01-19T05:00", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "file:///pack/app/journals_20190313_sn_only.jsonl", "startYear": "2014", "type": "Periodical", "url": "http://link.springer.com/journal/40801" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1051855'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1051855'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1051855'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1051855'


     

    This table displays all metadata directly associated to this object as RDF triples.

    60 TRIPLES      20 PREDICATES      28 URIs      21 LITERALS      8 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1051855 schema:about sg:ontologies/product-market-codes/B21007
    2 sg:ontologies/product-market-codes/H33002
    3 sg:ontologies/product-market-codes/H69000
    4 schema:description <p><i>Drugs - Real World Outcomes</i> targets research involving the use of real-world data to evaluate health outcomes and inform healthcare decision-making, with a particular focus on healthcare-related 'big data'. <i>Drugs - Real World Outcomes</i> has a broad scope, encompassing studies investigating drug utilisation, patterns of prescribing, pharmacovigilance, treatment guideline adherence, benefit-risk assessments, comparative effectiveness and economic analyses.</p><p><i>Drugs - Real World Outcomes</i> offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.<br/><br/>Upon acceptance for publication, manuscripts submitted to the journal will be subject to an article processing charge (APC) of US$2,200. Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of the APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) License, which does not permit commercial re-use ofthe article.</p>
    5 schema:editor Nbb344bad2c5342c693eb5b0a3f5b5437
    6 schema:inLanguage en
    7 schema:isAccessibleForFree true
    8 schema:issn 2198-9788
    9 2199-1154
    10 schema:license Fully Open Access
    11 schema:name Drugs - Real World Outcomes
    12 schema:productId N11a4b88c45fb4c7fa3989e4c87898ca8
    13 N240a543e1bb44dee94e046f491bdfc8a
    14 Nc23b3a041bd94682849a3464853ab7e0
    15 Nf42b10cf602b42adbced8e762618cbc1
    16 Nf4dd39958dec432c88526dbd70c16f67
    17 schema:publisher Ndcde16e38191417880ee9bcc6469933e
    18 schema:publisherImprint Adis
    19 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1051855
    20 schema:sdDatePublished 2021-01-19T05:00
    21 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    22 schema:sdPublisher N2b07df81187e4558a6349fbb3d2fb659
    23 schema:startYear 2014
    24 schema:url http://link.springer.com/journal/40801
    25 sgo:license sg:explorer/license/
    26 sgo:sdDataset journals
    27 rdf:type schema:Periodical
    28 N11a4b88c45fb4c7fa3989e4c87898ca8 schema:name dimensions_id
    29 schema:value 51855
    30 rdf:type schema:PropertyValue
    31 N240a543e1bb44dee94e046f491bdfc8a schema:name nsd_ids_id
    32 schema:value 489866
    33 rdf:type schema:PropertyValue
    34 N2b07df81187e4558a6349fbb3d2fb659 schema:name Springer Nature - SN SciGraph project
    35 rdf:type schema:Organization
    36 Nbb344bad2c5342c693eb5b0a3f5b5437 rdf:first Nc9fa337557004f12ae8a7021fcfc10d7
    37 rdf:rest rdf:nil
    38 Nc23b3a041bd94682849a3464853ab7e0 schema:name springer_id
    39 schema:value 40801
    40 rdf:type schema:PropertyValue
    41 Nc9fa337557004f12ae8a7021fcfc10d7 schema:familyName Peters
    42 schema:givenName Dene
    43 rdf:type schema:Person
    44 Ndcde16e38191417880ee9bcc6469933e schema:name Springer International Publishing
    45 rdf:type schema:Organization
    46 Nf42b10cf602b42adbced8e762618cbc1 schema:name lccn_id
    47 schema:value 2015243440
    48 rdf:type schema:PropertyValue
    49 Nf4dd39958dec432c88526dbd70c16f67 schema:name nlm_unique_id
    50 schema:value 101658456
    51 rdf:type schema:PropertyValue
    52 sg:ontologies/product-market-codes/B21007 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    53 schema:name Pharmacology/Toxicology
    54 rdf:type schema:DefinedTerm
    55 sg:ontologies/product-market-codes/H33002 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    56 schema:name Internal Medicine
    57 rdf:type schema:DefinedTerm
    58 sg:ontologies/product-market-codes/H69000 schema:inDefinedTermSet sg:ontologies/product-market-codes/
    59 schema:name Pharmacotherapy
    60 rdf:type schema:DefinedTerm
     




    Preview window. Press ESC to close (or click here)


    ...